FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066111680> ?p ?o ?g. }

• W2066111680 endingPage "94" @default.
• W2066111680 startingPage "76" @default.
• W2066111680 abstract "Periodontology 2000Volume 45, Issue 1 p. 76-94 Interference with immune-cell-mediated bone resorption in periodontal disease Xiaozhe Han, Xiaozhe HanSearch for more papers by this authorToshihisa Kawai, Toshihisa KawaiSearch for more papers by this authorMartin A. Taubman, Martin A. TaubmanSearch for more papers by this author Xiaozhe Han, Xiaozhe HanSearch for more papers by this authorToshihisa Kawai, Toshihisa KawaiSearch for more papers by this authorMartin A. Taubman, Martin A. TaubmanSearch for more papers by this author First published: 10 September 2007 https://doi.org/10.1111/j.1600-0757.2007.00215.xCitations: 48Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Aigner A. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J Biotechnol 2006: 124: 12–25. 2 Akatsu T, Murakami T, Nishikawa M, Ono K, Shinomiya N, Tsuda E, Mochizuki S, Yamaguchi K, Kinosaki M, Higashio K, Yamamoto M, Motoyoshi K, Nagata N. Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. Biochem Biophys Res Commun 1998: 250: 229–234. 3 Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993: 178: 669–674. 4 Alegre ML, Frauwirth KA, Thompson CB. T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 2001: 1: 220–228. 5 Alegre ML, Shiels H, Thompson CB, Gajewski TF. Expression and function of CTLA-4 in Th1 and Th2 cells. J Immunol 1998: 161: 3347–3356. 6 Anand DV, Lahiri A, Lim E, Hopkins D, Corder R. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J Am Coll Cardiol 2006: 47: 1850–1857. 7 Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC. CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999: 67: 2804–2809. 8 Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC. CD4(+) T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 1999: 67: 2804–2809. 9 Baker PJ, Garneau J, Howe L, Roopenian DC. T-cell contributions to alveolar bone loss in response to oral infection with Porphyromonas gingivalis. Acta Odontol Scand 2001: 59: 222–225. 10 Balto K, Sasaki H, Stashenko P. Interleukin-6 deficiency increases inflammatory bone destruction. Infect Immun 2001: 69: 744–750. 11 Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, Van Kooten C, Liu YJ, Rousset F, Saeland S. The CD40 antigen and its ligand. Annu Rev Immunol 1994: 12: 881–922. 12 Barbour SE, Nakashima K, Zhang JB, Tangada S, Hahn CL, Schenkein HA, Tew JG. Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med 1997: 8: 437–460. 13 Bateman TA, Dunstan CR, Ferguson VL, Lacey DL, Ayers RA, Simske SJ. Osteoprotegerin mitigates tail suspension-induced osteopenia. Bone 2000: 26: 443–449. 14 Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A 2001: 98: 9237–9242. 15 Becker BF, Gilles S, Sommerhoff CP, Zahler S. Application of peptides containing the cleavage sequence of pro-TNFalpha in assessing TACE activity of whole cells. Biol Chem 2002: 383: 1821–1826. 16 Bekker PJ, Holloway DL, Rasmussen AS, Murphy R, Martin SW, Leese PT, Holmes GB, Dunstan CR, DePaoli AM. A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 2004: 19: 1059–1066. 17 Berglundh T, Donati M. Aspects of adaptive host response in periodontitis. J Clin Periodontol 2005: 32(Suppl. 6): 87–107. 18 Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 2000: 12: 20–26. 19 Bhaskar SN, Levin MP, Frisch J. Plasma cell granuloma of periodontal tissues. Report of 45 cases. Periodontics 1968: 6: 272–276. 20 Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997: 385: 729–733. 21 Boumpas DT, Furie R, Manzi S, Illei GG, Wallace DJ, Balow JE, Vaishnaw A. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum 2003: 48: 719–727. 22 Brent LH, Butler JL, Woods WT Jr, Bubien JK. Transmembrane ion conductance in human B lymphocyte activation. J Immunol 1990: 145: 2381–2389. 23 Brown JE, Neville-Webbe H, Coleman RE. The role of bisphosphonates in breast and prostate cancers. Endocr Relat Cancer 2004: 11: 207–224. 24 Cahalan MD, Wulff H, Chandy KG. Molecular properties and physiological roles of ion channels in the immune system. J Clin Immunol 2001: 21: 235–252. 25 Chesneau V, Becherer JD, Zheng Y, Erdjument-Bromage H, Tempst P, Blobel CP. Catalytic properties of ADAM19. J Biol Chem 2003: 278: 22331–22340. 26 Choi Y. Role of TRAF6 in the immune system. Adv Exp Med Biol 2005: 560: 77–82. 27 Choi Y, Woo KM, Ko SH, Lee YJ, Park SJ, Kim HM, Kwon BS. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. Eur J Immunol 2001: 31: 2179–2188. 28 Cross AH, Girard TJ, Giacoletto KS, Evans RJ, Keeling RM, Lin RF, Trotter JL, Karr RW. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J Clin Invest 1995: 95: 2783–2789. 29 Crotti T, Smith MD, Hirsch R, Soukoulis S, Weedon H, Capone M, Ahern MJ, Haynes D. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 2003: 38: 380–387. 30 Dallas A, Vlassov AV. RNAi: a novel antisense technology and its therapeutic potential. Med Sci Monit 2006: 12: RA67–RA74. 31 Dello Sbarba P, Rovida E. Transmodulation of cell surface regulatory molecules via ectodomain shedding. Biol Chem 2002: 383: 69–83. 32 Dieli F, Gebbia N, Poccia F, Caccamo N, Montesano C, Fulfaro F, Arcara C, Valerio MR, Meraviglia S, Di Sano C, Sireci G, Salerno A. Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo. Blood 2003: 102: 2310–2311. 33 Dorner T, Burmester GR. The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr Opin Rheumatol 2003: 15: 246–252. 34 Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, Noelle RJ. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993: 261: 1328–1330. 35 Eastcott JW, Taubman MA, Shimauchi H, Smith DJ. Effect of adoptive transfer of Th1 clone cells on periodontal bone loss. J Dent Res 1994: 73: 159. 36 Ebersole JL, Cappelli D, Holt SC. Periodontal diseases: to protect or not to protect is the question? Acta Odontol Scand 2001: 59: 161–166. 37 Ebersole JL, Frey DE, Taubman MA, Haffajee AD, Socransky SS. Dynamics of systemic antibody responses in periodontal disease. J Periodontal Res 1987: 22: 184–186. 38 Ebersole JL, Frey DE, Taubman MA, Smith DJ, Socransky SS, Tanner AC. Serological identification of oral Bacteroides spp. by enzyme-linked immunosorbent assay. J Clin Microbiol 1984: 19: 639–644. 39 Ebersole JL, Taubman MA, Smith DJ, Frey DE, Haffajee AD, Socransky SS. Human serum antibody responses to oral microorganisms. IV. Correlation with homologous infection. Oral Microbiol Immunol 1987: 2: 53–59. 40 Emery P. The therapeutic potential of costimulatory blockade with CTLA4Ig in rheumatoid arthritis. Expert Opin Investig Drugs 2003: 12: 673–681. 41 Ernst CW, Lee JE, Nakanishi T, Karimbux NY, Rezende TM, Stashenko P, Seki M, Taubman MA, Kawai T. Diminished FOXP3/CD25 double positive Treg cells are associated with the increased RANKL+ T cells in bone resorption lesion of periodontal disease. Clin Exp Immunol 2007: In press. 42 Ezra A, Golomb G. Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Deliv Rev 2000: 42: 175–195. 43 Farrugia MC, Summerlin DJ, Krowiak E, Huntley T, Freeman S, Borrowdale R, Tomich C. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Laryngoscope 2006: 116: 115–120. 44 Freeman GJ, Borriello F, Hodes RJ, Reiser H, Gribben JG, Ng JW, Kim J, Goldberg JM, Hathcock K, Laszlo G, Lombard LA, Wang S, Gray GS, Nadler Sharpe AH. Murine B7-2 LM, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med 1993: 178: 2185–2192. 45 Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 1991: 174: 625–631. 46 Fujihashi K, Yamamoto M, Hiroi T, Bamberg TV, McGhee JR, Kiyono H. Selected Th1 and Th2 cytokine mRNA expression by CD4(+) T cells isolated from inflamed human gingival tissues. Clin Exp Immunol 1996: 103: 422–428. 47 Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, Silva JS. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006: 21: 12–20. 48 Gelman AE, Zhang J, Choi Y, Turka LA. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol 2004: 172: 6065–6073. 49 Goodman GR, Dissanayake IR, Bowman AR, Pun S, Ma Y, Jee WS, Bryer HP, Epstein S. Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss. Bone 2001: 28: 583–588. 50 Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998: 16: 111–135. 51 Han X, Kawai T, Eastcott JW, Taubman MA. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J Immunol 2006: 176: 625–631. 52 Han X, Lee S, Eastcott JW, Taubman MA. Effects of multiple Toll-like receptor signaling on immune cells. J Dent Res 2006: 85: 667. 53 Harada Y, Han X, Yamashita K, Kawai T, Eastcott JW, Smith DJ, Taubman MA. Effect of adoptive transfer of antigen-specific B cells on periodontal bone resorption. J Periodontal Res 2006: 41: 101–107. 54 Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992: 356: 607–609. 55 Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000: 408: 740–745. 56 Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000: 15: 2–12. 57 Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995: 182: 33–40. 58 Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 1999: 265: 144–150. 59 Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999: 162: 3749–3752. 60 Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 1995: 10: 1478–1487. 61 Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994: 76: 275–285. 62 Josien R, Wong RB, Li H, Steinman RM, Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999: 162: 2562–2568. 63 Kalunian KC, Davis JC Jr, Merrill JT, Totoritis MC, Wofsy D. Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002: 46: 3251–3258. 64 Katz J, Michalek SM. Effect of immune T cells derived from mucosal or systemic tissue on host responses to Porphyromonas gingivalis. Oral Microbiol Immunol 1998: 13: 73–80. 65 Kawai T, Eisen-Lev R, Seki M, Eastcott JW, Wilson ME, Taubman MA. Requirement of B7 costimulation for Th1-mediated inflammatory bone resorption in experimental periodontal disease. J Immunol 2000: 164: 2102–2109. 66 Kawai T, Makihira S, Oyoshi M, Lee JE, Tsitsikov EN, Taubman MA. TRAF1 negatively regulates RANKL-mediated TRAF6 signaling in osteoclastogenesis. J Dent Res 2005: 84: 355. 67 Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, Goncalves RB, Valverde P, Dibart S, Li YP, Miranda LA, Ernst CW, Izumi Y, Taubman MA. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006: 169: 987–998. 68 Kawai T, Paster BT, Komatsuzawa H, Ernst CW, Goncalves RB, Sasaki H, Ouhara K, Stashenko P, Sugai M, Taubman M. Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of RANKL-dependent periodontal bone resorption in a mouse model. Oral Microbiol Immunol 2007: 22: 208–215. 69 Kawai T, Shimauchi H, Eastcott JW, Smith DJ, Taubman MA. Antigen direction of specific T-cell clones into gingival tissues. Immunology 1998: 93: 11–19. 70 Khosla S. Magic bullets to kill nasty osteoclasts. Endocrinology 2005: 146: 3233–3234. 71 Kobayashi A, Hirano F, Makino I. The inhibitory effect of bisphosphonates on glucocorticoid-induced RANKL expression in human cells. Scand J Rheumatol 2005: 34: 480–484. 72 Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY. TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A 2004: 101: 3029–3034. 73 Kong YY, Boyle WJ, Penninger JM. Osteoprotegerin ligand: a common link between osteoclastogenesis, lymph node formation and lymphocyte development. Immunol Cell Biol 1999: 77: 188–193. 74 Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999: 402: 304–309. 75 Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999: 397: 315–323. 76 Koo GC, Blake JT, Shah K, Staruch MJ, Dumont F, Wunderler D, Sanchez M, McManus OB, Sirotina-Meisher A, Fischer P, Boltz RC, Goetz MA, Baker R, Bao J, Kayser F, Rupprecht KM, Parsons WH, Tong XC, Ita IE, Pivnichny J, Vincent S, Cunningham P, Hora D Jr, Feeney W, Kaczorowski G, Springer MS. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels. Cell Immunol 1999: 197: 99–107. 77 Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, Mulvany K, Hora D Jr, Cunningham P, Wunderler DL, McManus OB, Slaughter R, Bugianesi R, Felix J, Garcia M, Williamson J, Kaczorowski G, Sigal NH, Springer MS, Feeney W. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol 1997: 158: 5120–5128. 78 Kotake S, Nanke Y, Mogi M, Kawamoto M, Furuya T, Yago T, Kobashigawa T, Togari A, Kamatani N. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol 2005: 35: 3353–3363. 79 Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, Takahashi K, Furuya T, Ishiyama S, Kim KJ, Saito S, Nishikawa T, Takahashi N, Togari A, Tomatsu T, Suda T, Kamatani N. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 2001: 44: 1003–1012. 80 Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999: 103: 1345–1352. 81 Kukita A, Kukita T, Shin JH, Kohashi O. Induction of mononuclear precursor cells with osteoclastic phenotypes in a rat bone marrow culture system depleted of stromal cells. Biochem Biophys Res Commun 1993: 196: 1383–1389. 82 Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004: 15: 49–60. 83 Kwon BS, Wang S, Udagawa N, Haridas V, Lee ZH, Kim KK, Oh KO, Greene J, Li Y, Su J, Gentz R, Aggarwal BB, Ni J. TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB 1998: 12: 845–854. 84 Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998: 93: 165–176. 85 Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991: 174: 561–569. 86 Liu D, Xu JK, Figliomeni L, Huang L, Pavlos NJ, Rogers M, Tan A, Price P, Zheng MH. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med 2003: 11: 17–21. 87 Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J, Tempst P, Choi Y, Blobel CP. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 1999: 274: 13613–13618. 88 Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, Vargo-Gogola TC, Begtrup JL, Peterson TE, Fingleton B, Shirai T, Matrisian LM, Futakuchi M. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 2005: 7: 485–496. 89 Matsuda S, Shibasaki F, Takehana K, Mori H, Nishida E, Koyasu S. Two distinct action mechanisms of immunophilin–ligand complexes for the blockade of T-cell activation. EMBO Rep 2000: 1: 428–434. 90 Matsuyama T, Kawai T, Izumi Y, Taubman MA. Expression of major histocompatibility complex class II and CD80 by gingival epithelial cells induces activation of CD4+ T cells in response to bacterial challenge. Infect Immun 2005: 73: 1044–1051. 91 Matsuyama T, Kawai T, Taubman MA. OPG-L expression by T lymphocytes in periodontal diseased tissues. J Dent Res 2001: 80: 171. 92 McClung MR, Lewiecki EM, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman S, Chesnut CH, Murphy R, Holloway DL, Bekker PJ. AMG 162 increases bone mineral density (BMD) within 1 month in postmenopausal women with low BMD. J Bone Miner Res 2004: 19: S20. 93 McClung MR, Lewiecki EM, Cohen SB, Bolognese MA, Woodson GC, Moffett AH, Peacock M, Miller PD, Lederman SN, Chesnut CH, Lain D, Kivitz AJ, Holloway DL, Zhang C, Peterson MC, Bekker PJ. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 2006: 354: 821–831. 94 Michalek SM, Katz J, Childers NK, Martin M, Balkovetz DF. Microbial/host interactions: mechanisms involved in host responses to microbial antigens. Immunol Res 2002: 26: 223–234. 95 Mizuno A, Kanno T, Hoshi M, Shibata O, Yano K, Fujise N, Kinosaki M, Yamaguchi K, Tsuda E, Murakami A, Yasuda H, Higashio K. Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis. J Bone Miner Metab 2002: 20: 337–344. 96 Nabbe KC, Van Lent PL, Holthuysen AE, Sloetjes AW, Koch AE, Radstake TR, Van Den Berg WB. Local IL-13 gene transfer prior to immune-complex arthritis inhibits chondrocyte death and matrix-metalloproteinase-mediated cartilage matrix degradation despite enhanced joint inflammation. Arthritis Res Ther 2005: 7: R392–R401. 97 Nassar CA, Nassar PO, Abi Rached RS, Holzhausen M, Marcantonio E Jr, Spolidorio LC. Effect of cyclosporin A on alveolar bone homeostasis in a rat periodontitis model. J Periodontal Res 2004: 39: 143–148. 98 Norskov-Lauritsen N, Kilian M. Reclassification of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, Haemophilus paraphrophilus and Haemophilus segnis as Aggregatibacter actinomycetemcomitans gen. nov., comb. nov., Aggregatibacter aphrophilus comb. nov. and Aggregatibacter segnis comb. nov., and emended description of Aggregatibacter aphrophilus to include V factor-dependent and V factor-independent isolates. Int J Syst Evol Microbiol 2006: 56: 2135–2146. 99 O’Connor KC, Nguyen K, Stollar BD. Recognition of DNA by VH and Fv domains of an IgG anti-poly(dC) antibody with a singly mutated VH domain. J Mol Recognit 2001: 14: 18–28. 100 Orima K, Yamazaki K, Aoyagi T, Hara K. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue. Clin Exp Immunol 1999: 115: 153–160. 101 Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991: 26: 230–242. 102 Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway. J Biol Chem 2006: 281: 2414–2429. 103 Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res 1996: 11: 150–159. 104 Perrin PJ, Scott D, Quigley L, Albert PS, Feder O, Gray GS, Abe R, June CH, Racke MK. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J Immunol 1995: 154: 1481–1490. 105 Pype S, Declercq W, Ibrahimi A, Michiels C, Van Rietschoten JG, Dewulf N, De Boer M, Vandenabeele P, Huylebroeck D, Remacle JE. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J Biol Chem 2000: 275: 18586–18593. 106 Rondinone CM. Therapeutic potential of RNAi in metabolic diseases. Biotechniques 2006: 42: Suppl 31–36. 107 Rovira P, Mascarell L, Truffa-Bachi P. The impact of immunosuppressive drugs on the analysis of T cell activation. Curr Med Chem 2000: 7: 673–692. 108 Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005: 6: 345–352. 109 Salesi N, Pistilli R, Marcelli V, Govoni FA, Bozza F, Bossone G, Venturelli V, Di Cocco B, Pacetti U, Ciorra A, Di Fonso C, Cortesi E, Veltri E, Vecchione A. Bisphosphonates and oral cavity avascular bone necrosis: a review of twelve cases. Anticancer Res 2006: 26: 3111–3115. 110 Sasaki H, Hou L, Belani A, Wang CY, Uchiyama T, Muller R, Stashenko P. IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol 2000: 165: 3626–3630. 111 Sasaki H, Okamatsu Y, Kawai T, Kent R, Taubman MA, Stashenko P. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J Periodontal Res 2004: 39: 432–441. 112 Schlondorff J, Lum L, Blobel CP. Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase. J Biol Chem 2001: 276: 14665–14674. 113 Schmidt A, Rutledge SJ, Endo N, Opas EE, Tanaka H, Wesolowski G, Leu CT, Huang Z, Ramachandaran C, Rodan SB, Rodan GA. Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate. Proc Natl Acad Sci U S A 1996: 93: 3068–3073. 114 Seymour GJ, Powell RN, Davies WI. The immunopathogenesis of progressive chronic inflammatory periodontal disease. J Oral Pathol 1979: 8: 249–265. 115 Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002: 2: 116–126. 116 Stoufi ED, Taubman MA, Ebersole JL, Smith DJ, Stashenko PP. Phenotypic analyses of mononuclear cells recovered from healthy and diseased human periodontal tissues. J Clin Immunol 1987: 7: 235–245. 117 Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999: 20: 345–357. 118 Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol 2005: 32: 369–374. 119 Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000: 408: 600–605. 120 Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004: 16: 3–9. 121 Takeichi O, Haber J, Kawai T, Smith DJ, Moro I, Taubman MA. Cyto" @default.
• W2066111680 created "2016-06-24" @default.
• W2066111680 creator A5003207744 @default.
• W2066111680 creator A5007239313 @default.
• W2066111680 creator A5057605690 @default.
• W2066111680 date "2007-09-10" @default.
• W2066111680 modified "2023-10-18" @default.
• W2066111680 title "Interference with immune-cell-mediated bone resorption in periodontal disease" @default.
• W2066111680 cites W1489480103 @default.
• W2066111680 cites W1492213776 @default.
• W2066111680 cites W1503366574 @default.
• W2066111680 cites W1511403203 @default.
• W2066111680 cites W1514540900 @default.
• W2066111680 cites W1516750105 @default.
• W2066111680 cites W1534645474 @default.
• W2066111680 cites W1537686225 @default.
• W2066111680 cites W1567309370 @default.
• W2066111680 cites W1574748667 @default.
• W2066111680 cites W1618470343 @default.
• W2066111680 cites W1639854378 @default.
• W2066111680 cites W1677043489 @default.
• W2066111680 cites W1759314672 @default.
• W2066111680 cites W1910581214 @default.
• W2066111680 cites W1910853730 @default.
• W2066111680 cites W1914559464 @default.
• W2066111680 cites W1950448919 @default.
• W2066111680 cites W1963138732 @default.
• W2066111680 cites W1973683306 @default.
• W2066111680 cites W1975490391 @default.
• W2066111680 cites W1978926805 @default.
• W2066111680 cites W1981860093 @default.
• W2066111680 cites W1982310023 @default.
• W2066111680 cites W1987608927 @default.
• W2066111680 cites W1989914829 @default.
• W2066111680 cites W1991974261 @default.
• W2066111680 cites W1994969460 @default.
• W2066111680 cites W1998719248 @default.
• W2066111680 cites W2004434363 @default.
• W2066111680 cites W2004708987 @default.
• W2066111680 cites W2007106389 @default.
• W2066111680 cites W2008950531 @default.
• W2066111680 cites W2009154052 @default.
• W2066111680 cites W2009818084 @default.
• W2066111680 cites W2010825373 @default.
• W2066111680 cites W2012241435 @default.
• W2066111680 cites W2017237496 @default.
• W2066111680 cites W2018602999 @default.
• W2066111680 cites W2020697659 @default.
• W2066111680 cites W2021154537 @default.
• W2066111680 cites W2022114062 @default.
• W2066111680 cites W2026950582 @default.
• W2066111680 cites W2027239786 @default.
• W2066111680 cites W2028077169 @default.
• W2066111680 cites W2028460474 @default.
• W2066111680 cites W2029957805 @default.
• W2066111680 cites W2032876833 @default.
• W2066111680 cites W2033085036 @default.
• W2066111680 cites W2033793521 @default.
• W2066111680 cites W2034014808 @default.
• W2066111680 cites W2037770361 @default.
• W2066111680 cites W2038118004 @default.
• W2066111680 cites W2040572245 @default.
• W2066111680 cites W2041597638 @default.
• W2066111680 cites W2041974941 @default.
• W2066111680 cites W2044482752 @default.
• W2066111680 cites W2044533820 @default.
• W2066111680 cites W2048056228 @default.
• W2066111680 cites W2048299560 @default.
• W2066111680 cites W2048346627 @default.
• W2066111680 cites W2049299404 @default.
• W2066111680 cites W2050311730 @default.
• W2066111680 cites W2051596822 @default.
• W2066111680 cites W2053922350 @default.
• W2066111680 cites W2054216140 @default.
• W2066111680 cites W2054538838 @default.
• W2066111680 cites W2055166353 @default.
• W2066111680 cites W2055479809 @default.
• W2066111680 cites W2057121293 @default.
• W2066111680 cites W2058423486 @default.
• W2066111680 cites W2062053382 @default.
• W2066111680 cites W2063048904 @default.
• W2066111680 cites W2065297127 @default.
• W2066111680 cites W2065585172 @default.
• W2066111680 cites W2066521125 @default.
• W2066111680 cites W2067981232 @default.
• W2066111680 cites W2068488477 @default.
• W2066111680 cites W2069508816 @default.
• W2066111680 cites W2069981713 @default.
• W2066111680 cites W2072930832 @default.
• W2066111680 cites W2074035141 @default.
• W2066111680 cites W2074661703 @default.
• W2066111680 cites W2074881372 @default.
• W2066111680 cites W2075336785 @default.
• W2066111680 cites W2076104207 @default.
• W2066111680 cites W2077248910 @default.
• W2066111680 cites W2083019332 @default.
• W2066111680 cites W2085971419 @default.
• W2066111680 cites W2087013294 @default.

• next